Exact Mass: 297.0992

Exact Mass Matches: 297.0992

Found 191 metabolites which its exact mass value is equals to given mass value 297.0992, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-methylthioadenosine (MTA)

(2R,3R,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[(methylsulfanyl)methyl]oxolane-3,4-diol

C11H15N5O3S (297.0896)


5-Methylthioadenosine, also known as MTA or thiomethyladenosine, belongs to the class of organic compounds known as 5-deoxy-5-thionucleosides. These are 5-deoxyribonucleosides in which the ribose is thio-substituted at the 5position by a S-alkyl group. 5-Methylthioadenosine is metabolized solely by MTA-phosphorylase, to yield 5-methylthioribose-1-phosphate and adenine, a crucial step in the methionine and purine salvage pathways, respectively. 5-Methylthioadenosine exists in all living species, ranging from bacteria to humans. 5-Methylthioadenosine (MTA) is a naturally occurring sulfur-containing nucleoside present in all mammalian tissues. Within humans, 5-methylthioadenosine participates in a number of enzymatic reactions. In particular, 5-methylthioadenosine and spermidine can be biosynthesized from S-adenosylmethioninamine and putrescine through the action of the enzyme spermidine synthase. In addition, 5-methylthioadenosine can be converted into 5-methylthioribose 1-phosphate and L-methionine; which is catalyzed by the enzyme S-methyl-5-thioadenosine phosphorylase. It is produced from S-adenosylmethionine mainly through the polyamine biosynthetic pathway, where it behaves as a powerful inhibitory product. For instance, 5-Methylthioadenosine has been shown to influence the regulation of gene expression, proliferation, differentiation, and apoptosis (PMID:15313459). In humans, 5-methylthioadenosine is involved in the metabolic disorder called hypermethioninemia. Outside of the human body, 5-Methylthioadenosine has been detected, but not quantified in several different foods, such as soursops, allspices, summer grapes, alaska wild rhubarbs, and breadfruits. Elevated excretion appears in children with severe combined immunodeficiency syndrome (SCID) (PMID:3987052). Evidence suggests that 5-Methylthioadenosine can affect cellular processes in many ways. 5-Methylthioadenosine can be found in human urine. 5-deoxy-5-methylthioadenosine, also known as S-methyl-5-thioadenosine or mta, is a member of the class of compounds known as 5-deoxy-5-thionucleosides. 5-deoxy-5-thionucleosides are 5-deoxyribonucleosides in which the ribose is thio-substituted at the 5position by a S-alkyl group. 5-deoxy-5-methylthioadenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-deoxy-5-methylthioadenosine can be found in a number of food items such as allspice, sesame, roselle, and bayberry, which makes 5-deoxy-5-methylthioadenosine a potential biomarker for the consumption of these food products. 5-deoxy-5-methylthioadenosine can be found primarily in blood and urine, as well as in human fibroblasts, platelet and prostate tissues. 5-deoxy-5-methylthioadenosine exists in all living species, ranging from bacteria to humans. In humans, 5-deoxy-5-methylthioadenosine is involved in a couple of metabolic pathways, which include methionine metabolism and spermidine and spermine biosynthesis. 5-deoxy-5-methylthioadenosine is also involved in several metabolic disorders, some of which include glycine n-methyltransferase deficiency, methionine adenosyltransferase deficiency, homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblg complementation type, and hypermethioninemia. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2].

   

Psicofuranine

9-D-Psicofuranosyl-6-aminopurine

C11H15N5O5 (297.1073)


   

Longifolonine

Longifolonine

C17H15NO4 (297.1001)


   

Musk xylene

1-(1,1-Dimethylethyl)-3,5-dimethyl-2,4,6-trinitrobenzene

C12H15N3O6 (297.0961)


Flavouring compound [Superscent]

   

2-Methylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-6,9-dihydro-3H-purin-6-one

C11H15N5O5 (297.1073)


2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127) [HMDB] 2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127). N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

   

1-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6,9-dihydro-1H-purin-6-one

C11H15N5O5 (297.1073)


1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours. These nucleosides have been proposed as tumour markers. Their measurement could provide a non-invasive diagnostic method, help identify different cancers, and monitor any therapeutic effects (PMID:9129323). 1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours and they have been proposed as tumour markers. Their 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

   

3'-O-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-6,9-dihydro-3H-purin-6-one

C11H15N5O5 (297.1073)


3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933). 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

(S)-Annocherine A

1-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

C17H15NO4 (297.1001)


(R)-Annocherine A is found in fruits. (R)-Annocherine A is an alkaloid from the leaves of Annona cherimola (cherimoya).

   

Nelarabine

(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


Nelarabine is only found in individuals that have used or taken this drug. It is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in inhibition of DNA synthesis and cytotoxicity.Once nelarabine is metabolized into ara-GTP, the metabolite accumulates in leukemic blasts and incorporates into DNA to exert its S phase-specific cytotoxic effects, leading to the induction of fragmentation and apoptosis. Ara-GTP competes with endogenous deoxyGTP (dGTP) for incorporation into DNA. Once ara-GTP is incorporated at the 3 end of DNA, further DNA elongation is inhibited, which signals apoptosis and leads to cellular destruction. Additional cytotoxic activities may exist, but these are not fully understood. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

   

2'-C-Methylguanosine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C11H15N5O5 (297.1073)


   

(2R,5S)-2-(6-Aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol

(2R,5S)-2-(6-Aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol

C11H15N5O3S (297.0896)


   

Teroxirone

tris[(oxiran-2-yl)methyl]-1,3,5-triazinane-2,4,6-trione

C12H15N3O6 (297.0961)


   

Tritiozine

4-(3,4,5-Trimethoxythiobenzoyl)tetrahydro-1,4-oxazine

C14H19NO4S (297.1035)


   

Fe(II)-nicotianamine

Fe(II)-nicotianamine

C12H15N3O6 (297.0961)


Fe(ii)-nicotianamine is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Fe(ii)-nicotianamine can be found in a number of food items such as chanterelle, amaranth, bitter gourd, and brazil nut, which makes fe(ii)-nicotianamine a potential biomarker for the consumption of these food products.

   

Papaveroline, 6-O-methyl-

Papaveroline, 6-O-methyl-

C17H15NO4 (297.1001)


   

Prooxocryptochine

Prooxocryptochine

C17H15NO4 (297.1001)


   

Norcularicine

Norcularicine

C17H15NO4 (297.1001)


   

2-O-methylguanosine

2`-O-Methylguanosine

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the hydroxyl at position C-2 substituted with a methyl group. CONFIDENCE standard compound; INTERNAL_ID 318 2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2’-O-methyltransferase. 2'-O-Methylguanosine results in apoptotic changes of cells[1][2].

   

Triglycidyl isocyanurate

Triglycidyl isocyanurate

C12H15N3O6 (297.0961)


D000970 - Antineoplastic Agents Triglycidyl isocyanurate (TGIC; Teroxirone) is a triazene triepoxide with antiangiogenic and antineoplastic activities. Triglycidyl isocyanurate inhibits the growth of non-small-cell-lung cancer cells via?p53 activation. Triglycidyl isocyanurate induces cell apoptosis. Triglycidyl isocyanurate can be used for cancer research[1][2].

   

1-[(Benzyloxy)carbonyl]-2-indolinecarboxylic acid

1-[(Benzyloxy)carbonyl]-2-indolinecarboxylic acid

C17H15NO4 (297.1001)


   

Maybridge3_004494

Maybridge3_004494

C15H15N5S (297.1048)


   

N(6)-OH-Me-Adenosine

N(6)-OH-Me-Adenosine

C11H15N5O5 (297.1073)


consensus spectrum

   

7-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-6-oxo-6,7-dihydro-3H-1,3,7,9$l^{5}-purin-9-ylium

C11H15N5O5 (297.1073)


   

4xi-hydroxy-(1rC2)-spiro[cyclohexane-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-2-one|scortechiniine B

4xi-hydroxy-(1rC2)-spiro[cyclohexane-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-2-one|scortechiniine B

C17H15NO4 (297.1001)


   

6-Hydroxygalanthindole

6-Hydroxygalanthindole

C17H15NO4 (297.1001)


   

Desmosine[alkaloid]

Desmosine[alkaloid]

C17H15NO4 (297.1001)


   

Adenosine, 2-methoxy-

Adenosine, 2-methoxy-

C11H15N5O5 (297.1073)


   
   

SCHEMBL14614880

SCHEMBL14614880

C11H15N5O5 (297.1073)


   
   

MCULE-5651531235

MCULE-5651531235

C17H15NO4 (297.1001)


   

Canelillinoxine

Canelillinoxine

C17H15NO4 (297.1001)


   

piperolactam D

piperolactam D

C17H15NO4 (297.1001)


   

N-Acetylglycylclavaminic acid

N-Acetylglycylclavaminic acid

C12H15N3O6 (297.0961)


   

Ac-1-Hydroxy-3-methoxy-10-methylacridone

Ac-1-Hydroxy-3-methoxy-10-methylacridone

C17H15NO4 (297.1001)


   

Nelarabine

Nelarabine (Arranon)

C11H15N5O5 (297.1073)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

   
   

Methylthioadenosine

(2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol

C11H15N5O3S (297.0896)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents Adenosine with the hydroxy group at C-5 substituted with a methylthio (methylsulfanyl) group. COVID info from COVID-19 Disease Map D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-(Methylthio)adenosine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2457-80-9 (retrieved 2024-11-05) (CAS RN: 2457-80-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

1-methylguanosine

1-methylguanosine

C11H15N5O5 (297.1073)


Guanosine substituted with a methyl group at position N-1. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

   

3-O-Methylguanosine

Guanosine, 3-O-methyl-

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the hydroxyl at position C-3 substituted with a methyl group. 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

5-Methylthioadenosine

5-Methylthioadenosine

C11H15N5O3S (297.0896)


   

N2-Methylguanosine

N2-Methylguanosine

C11H15N5O5 (297.1073)


   

N-Methylguanosine

N(2)-Methylguanosine

C11H15N5O5 (297.1073)


CONFIDENCE standard compound; INTERNAL_ID 319 N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

   

Adenosine + C2H5S

Adenosine + C2H5S

C11H15N5O3S (297.0896)


Annotation level-2

   

Methylthioadenosine

Adenylthiomethylpentose

C11H15N5O3S (297.0896)


5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2]. 5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine) is a nucleoside generated from S-adenosylmethionine (SAM) during polyamine synthesis[1]. 5'-Methylthioadenosine suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. 5'-Methylthioadenosine and its associated materials have striking regulatory effects on tumorigenesis[2].

   

5'-METHYLTHIOADENOSINE

5'-METHYLTHIOADENOSINE

C11H15N5O3S (297.0896)


   

N1-Methylguanosine; LC-tDDA; CE10

N1-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE20

N1-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE30

N1-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE40

N1-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE0; CorrDec

7-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE10; CorrDec

7-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE30; CorrDec

7-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE0; MS2Dec

7-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE10; MS2Dec

7-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE30; MS2Dec

7-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE0; CorrDec

N2-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE10; CorrDec

N2-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE30; CorrDec

N2-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE0; MS2Dec

N2-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE10; MS2Dec

N2-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE30; MS2Dec

N2-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE0; CorrDec

N1-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE10; CorrDec

N1-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE30; CorrDec

N1-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE0; MS2Dec

N1-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE10; MS2Dec

N1-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE30; MS2Dec

N1-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

5-S-Methylthioadenosine; AIF; CE0; CorrDec

5-S-Methylthioadenosine; AIF; CE0; CorrDec

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; AIF; CE10; CorrDec

5-S-Methylthioadenosine; AIF; CE10; CorrDec

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; AIF; CE30; CorrDec

5-S-Methylthioadenosine; AIF; CE30; CorrDec

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; AIF; CE0; MS2Dec

5-S-Methylthioadenosine; AIF; CE0; MS2Dec

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; AIF; CE10; MS2Dec

5-S-Methylthioadenosine; AIF; CE10; MS2Dec

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; AIF; CE30; MS2Dec

5-S-Methylthioadenosine; AIF; CE30; MS2Dec

C11H15N5O3S (297.0896)


   

7-Methylguanosine; LC-tDDA; CE10

7-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE20

7-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE30

7-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE40

7-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE10

N2-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE20

N2-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE30

N2-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE40

N2-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

5-S-Methylthioadenosine; LC-tDDA; CE10

5-S-Methylthioadenosine; LC-tDDA; CE10

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; LC-tDDA; CE20

5-S-Methylthioadenosine; LC-tDDA; CE20

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; LC-tDDA; CE30

5-S-Methylthioadenosine; LC-tDDA; CE30

C11H15N5O3S (297.0896)


   

5-S-Methylthioadenosine; LC-tDDA; CE40

5-S-Methylthioadenosine; LC-tDDA; CE40

C11H15N5O3S (297.0896)


   

N6-Hydroxymethyl-adenosine

N6-Hydroxymethyl-adenosine

C11H15N5O5 (297.1073)


   

3-OMG

Guanosine, 3-O-methyl-

C11H15N5O5 (297.1073)


3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

L-Menthone 1,2-glycerol ketal

3-(benzylsulfanyl)-5-(2-methoxyphenyl)-1H-1,2,4-triazole

C16H15N3OS (297.0936)


   

(S)-Annocherine A

1-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

C17H15NO4 (297.1001)


   

L-Leucine,N-(2,4-dinitrophenyl)-

L-Leucine,N-(2,4-dinitrophenyl)-

C12H15N3O6 (297.0961)


   

1-BENZYL-5-(4-CHLOROPHENYL)-2,3-DIHYDRO-4-PYRIDINONE

1-BENZYL-5-(4-CHLOROPHENYL)-2,3-DIHYDRO-4-PYRIDINONE

C18H16ClNO (297.092)


   

5-OXO-1-(4-PHENOXYPHENYL)PYRROLIDINE-3-CARBOXYLICACID

5-OXO-1-(4-PHENOXYPHENYL)PYRROLIDINE-3-CARBOXYLICACID

C17H15NO4 (297.1001)


   

4-[4-(BENZYLOXY)PHENYL]-5-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

4-[4-(BENZYLOXY)PHENYL]-5-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C16H15N3OS (297.0936)


   

ISOCYANURIC ACID (S,S,S)-TRIGLYCIDYL ESTER

ISOCYANURIC ACID (S,S,S)-TRIGLYCIDYL ESTER

C12H15N3O6 (297.0961)


   

4-(BENZYLOXY)-2-(CHLOROMETHYL)-3-METHYLQUINOLINE

4-(BENZYLOXY)-2-(CHLOROMETHYL)-3-METHYLQUINOLINE

C18H16ClNO (297.092)


   

4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

C14H14F3N3O (297.1089)


   

TRANS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

TRANS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

C11H20FNO5S (297.1046)


   

CIS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

CIS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

C11H20FNO5S (297.1046)


   

Methyl N-[(benzyloxy)carbonyl]-L-methioninate

Methyl N-[(benzyloxy)carbonyl]-L-methioninate

C14H19NO4S (297.1035)


   

2-((tert-Butyldimethylsilyloxy)methyl)-6-chlorofuro[3,2-b]pyridine

2-((tert-Butyldimethylsilyloxy)methyl)-6-chlorofuro[3,2-b]pyridine

C14H20ClNO2Si (297.0952)


   

6-((2,4-Dinitrophenyl)amino)hexanoic acid

N-(2,4-DINITROPHENYL)-6-AMINOHEXANOIC ACID

C12H15N3O6 (297.0961)


   

2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid

2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid

C14H19NO4S (297.1035)


   

(S)2,3-DIHYDRO-INDOLE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER

(S)2,3-DIHYDRO-INDOLE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER

C17H15NO4 (297.1001)


   

(1-AMINO-PYRROLIDIN-3-YL)-METHANOL

(1-AMINO-PYRROLIDIN-3-YL)-METHANOL

C17H15NO4 (297.1001)


   

TRIETHYL 1 3 5-TRIAZINE-2 4 6-TRICARBOX&

TRIETHYL 1 3 5-TRIAZINE-2 4 6-TRICARBOX&

C12H15N3O6 (297.0961)


   

1-(MESITYLSULFONYL)PYRROLIDINE-2-CARBOXYLIC ACID

1-(MESITYLSULFONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C14H19NO4S (297.1035)


   
   

1H-Indole-2-carboxylicacid, 5-methoxy-6-(phenylmethoxy)-

1H-Indole-2-carboxylicacid, 5-methoxy-6-(phenylmethoxy)-

C17H15NO4 (297.1001)


   

4-(toluene-4-sulfonylamino)-cyclohexanecarboxylic acid

4-(toluene-4-sulfonylamino)-cyclohexanecarboxylic acid

C14H19NO4S (297.1035)


   
   

1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid

1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid

C17H15NO4 (297.1001)


   

(R,R)-I-PR-DUPHOS

(R,R)-I-PR-DUPHOS

C12H15N3O6 (297.0961)


   

8-Acetyl-6-benzyloxy-4H-benzo[1,4]oxazin-3-one

8-Acetyl-6-benzyloxy-4H-benzo[1,4]oxazin-3-one

C17H15NO4 (297.1001)


   

Fmoc-Gly-OH-15N

Fmoc-Gly-OH-15N

C17H15NO4 (297.1001)


   

8-acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one

8-acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one

C17H15NO4 (297.1001)


   

5-(2-METHOXYPHENYL)-4-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

5-(2-METHOXYPHENYL)-4-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C16H15N3OS (297.0936)


   

2-isonicotinoyl-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-isonicotinoyl-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

C17H15NO4 (297.1001)


   

L-Isoleucine,N-(2,4-dinitrophenyl)-

L-Isoleucine,N-(2,4-dinitrophenyl)-

C12H15N3O6 (297.0961)


   

2-C-Methylguanosine

2-C-Methylguanosine

C11H15N5O5 (297.1073)


   

2-BENZAMIDO-3-(4-METHOXYPHENYL)ACRYLIC ACID

2-BENZAMIDO-3-(4-METHOXYPHENYL)ACRYLIC ACID

C17H15NO4 (297.1001)


   

n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide

n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide

C11H15N5O5 (297.1073)


   

Methapyrilene Hydrochloride

Methapyrilene Hydrochloride

C14H20ClN3S (297.1066)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Boc-GlyP(O)(OMe)2OMe

Boc-GlyP(O)(OMe)2OMe

C10H20NO7P (297.0977)


   

Tritiozine

Tritiozine

C14H19NO4S (297.1035)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent Trithiozine is an orally active antisecretory and antiulcer agent. Trithiozine can be used for the research of peptic ulcer disease and hypersecretory disorders[1].

   

Isofagomine D-Tartrate

Isofagomine D-Tartrate

C10H19NO9 (297.106)


   

8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one

8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one

C17H15NO4 (297.1001)


   

(2Z)-5,6-Dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1-indanone

(2Z)-5,6-Dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1-indanone

C17H15NO4 (297.1001)


   

Toluene-4-sulfonic acid (S)-1-acetyl-pyrrolidin-2-ylMethyl ester

Toluene-4-sulfonic acid (S)-1-acetyl-pyrrolidin-2-ylMethyl ester

C14H19NO4S (297.1035)


   

(2-benzylidene-3-oxo-benzofuran-6-yl) acetate

(2-benzylidene-3-oxo-benzofuran-6-yl) acetate

C12H16ClN5O2 (297.0992)


   

Pentafluorophenyldimethylsilyldiethylamine

Pentafluorophenyldimethylsilyldiethylamine

C12H16F5NSi (297.0972)


   

Tanaproget

Tanaproget

C16H15N3OS (297.0936)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

Teroxirone

Teroxirone

C12H15N3O6 (297.0961)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

Afegostat tartrate

Afegostat tartrate

C10H19NO9 (297.106)


C87006 - Pharmacological Chaperone

   

5-Methylthioformycin

5-Methylthioformycin

C11H15N5O3S (297.0896)


D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D005573 - Formycins

   

beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-5-S-methyl-5-thio-

beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-5-S-methyl-5-thio-

C11H15N5O3S (297.0896)


   

2-[[(E)-3-(4-methoxyphenyl)prop-2-enoyl]amino]benzoic acid

2-[[(E)-3-(4-methoxyphenyl)prop-2-enoyl]amino]benzoic acid

C17H15NO4 (297.1001)


   

3-[(4-methylphenoxy)methyl]-4-phenyl-1H-1,2,4-triazole-5-thione

3-[(4-methylphenoxy)methyl]-4-phenyl-1H-1,2,4-triazole-5-thione

C16H15N3OS (297.0936)


   

1-(2,4-Dimethylphenyl)-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)ethanone

1-(2,4-Dimethylphenyl)-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)ethanone

C16H15N3OS (297.0936)


   

N7-Methylguanosine

N7-Methylguanosine

C11H15N5O5 (297.1073)


   

(2s)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

(2s)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

C17H16ClN3 (297.1033)


   

(2r)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

(2r)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

C17H16ClN3 (297.1033)


   

3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-D]pyrimidin-7-YL)pyrrolidinium

3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-D]pyrimidin-7-YL)pyrrolidinium

C12H17N4O3S+ (297.1021)


   

Adenosine, N-(hydroxymethyl)-

Adenosine, N-(hydroxymethyl)-

C11H15N5O5 (297.1073)


   

Guanosine, 1-methyl-

Guanosine, 1-methyl-

C11H15N5O5 (297.1073)


   
   

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one

C11H15N5O5 (297.1073)


   

(5Z)-2-(2-methylanilino)-5-[(1-methylpyrrol-2-yl)methylidene]-1,3-thiazol-4-one

(5Z)-2-(2-methylanilino)-5-[(1-methylpyrrol-2-yl)methylidene]-1,3-thiazol-4-one

C16H15N3OS (297.0936)


   

N-cyclopropyl-3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxamide

N-cyclopropyl-3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxamide

C16H15N3OS (297.0936)


   

8-(1H-indol-3-ylmethylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione

8-(1H-indol-3-ylmethylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione

C17H15NO4 (297.1001)


   

4-Amino-5-[(4-methylphenyl)-oxomethyl]-2-(prop-2-enylamino)-3-thiophenecarbonitrile

4-Amino-5-[(4-methylphenyl)-oxomethyl]-2-(prop-2-enylamino)-3-thiophenecarbonitrile

C16H15N3OS (297.0936)


   

2-[(2,5-Dimethylphenyl)methylthio]-5-(3-pyridinyl)-1,3,4-oxadiazole

2-[(2,5-Dimethylphenyl)methylthio]-5-(3-pyridinyl)-1,3,4-oxadiazole

C16H15N3OS (297.0936)


   

(Z)-4-[3-(benzylamino)phenyl]-2-hydroxy-4-oxo-but-2-enoic acid

(Z)-4-[3-(benzylamino)phenyl]-2-hydroxy-4-oxo-but-2-enoic acid

C17H15NO4 (297.1001)


   

3-[(3-chlorophenyl)methylthio]-N-cyclopentylpropanamide

3-[(3-chlorophenyl)methylthio]-N-cyclopentylpropanamide

C15H20ClNOS (297.0954)


   

2-(3-imidazo[1,5-a]pyridinylthio)-N-(4-methylphenyl)acetamide

2-(3-imidazo[1,5-a]pyridinylthio)-N-(4-methylphenyl)acetamide

C16H15N3OS (297.0936)


   

N-{[(4-methyl-2-pyridinyl)amino]carbonothioyl}-3-phenylacrylamide

N-{[(4-methyl-2-pyridinyl)amino]carbonothioyl}-3-phenylacrylamide

C16H15N3OS (297.0936)


   

Methyl 2-[(2-methoxyacetyl)amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

Methyl 2-[(2-methoxyacetyl)amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C14H19NO4S (297.1035)


   

methyl 2-[(butoxycarbonyl)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

methyl 2-[(butoxycarbonyl)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

C14H19NO4S (297.1035)


   

1-[(6-chloro-2-imidazo[1,2-a]pyridinyl)methyl]-3,4-dihydro-2H-quinoline

1-[(6-chloro-2-imidazo[1,2-a]pyridinyl)methyl]-3,4-dihydro-2H-quinoline

C17H16ClN3 (297.1033)


   

4-({[3,5-Dimethyl-4-(methylthio)phenoxy]carbonyl}amino)butanoic acid

4-({[3,5-Dimethyl-4-(methylthio)phenoxy]carbonyl}amino)butanoic acid

C14H19NO4S (297.1035)


   

2-Methoxyadenosine

2-Methoxyadenosine

C11H15N5O5 (297.1073)


   
   

N(2)-Methylguanosine

N(2)-Methylguanosine

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the amine at position N-2 substituted with a methyl group.

   

2'-O-Methylguanosine

2'-O-Methylguanosine

C11H15N5O5 (297.1073)


   

O-Methylguanosine

O-Methylguanosine

C11H15N5O5 (297.1073)


   

6-O-Methyl Guanosine

6-O-Methyl Guanosine

C11H15N5O5 (297.1073)


6-O-Methyl Guanosine is a modified nucleoside[1]. 6-O-Methyl Guanosine (6-methylguanosine) inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line[2].

   

7-Methylguanosine

7-Methylguanosine

C11H15N5O5 (297.1073)


7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM. 7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM.

   

3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone

NA

C17H15NO4 (297.1001)


{"Ingredient_id": "HBIN007476","Ingredient_name": "3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone","Alias": "NA","Ingredient_formula": "C17H15NO4","Ingredient_Smile": "NA","Ingredient_weight": "297.31","OB_score": "NA","CAS_id": "189098-75-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8488","PubChem_id": "NA","DrugBank_id": "NA"}

   

alpha-D-Arabinofuranosyladenine

(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910

C11H15N5O5 (297.1073)


{"Ingredient_id": "HBIN015484","Ingredient_name": "alpha-D-Arabinofuranosyladenine","Alias": "(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910","Ingredient_formula": "C11H15N5O5","Ingredient_Smile": "C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N","Ingredient_weight": "297.27","OB_score": "20.89729146","CAS_id": "6936-84-1","SymMap_id": "SMIT12080","TCMID_id": "NA","TCMSP_id": "MOL011145","TCM_ID_id": "NA","PubChem_id": "96368","DrugBank_id": "NA"}

   

annocherine a

NA

C17H15NO4 (297.1001)


{"Ingredient_id": "HBIN016208","Ingredient_name": "annocherine a","Alias": "NA","Ingredient_formula": "C17H15NO4","Ingredient_Smile": "COC1=C(C=C2C(=C1)C=CN=C2C(C3=CC=C(C=C3)O)O)O","Ingredient_weight": "297.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1298","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "637078","DrugBank_id": "NA"}

   

3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-1h-indol-2-one

3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-1h-indol-2-one

C17H15NO4 (297.1001)


   

(3ar,7as)-3a-hydroxy-1-[(2e)-3-phenylprop-2-enoyl]-7,7a-dihydro-3h-indole-2,6-dione

(3ar,7as)-3a-hydroxy-1-[(2e)-3-phenylprop-2-enoyl]-7,7a-dihydro-3h-indole-2,6-dione

C17H15NO4 (297.1001)


   

1-[(r)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

1-[(r)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

C17H15NO4 (297.1001)


   

(1s,4r)-4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

(1s,4r)-4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

C17H15NO4 (297.1001)


   

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-5-methyl-4-sulfanyloxolan-3-ol

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-5-methyl-4-sulfanyloxolan-3-ol

C11H15N5O3S (297.0896)


   

(2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


   

4-hydroxy-12,17-dimethyl-13-oxa-16-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(17),3,5,7,10-pentaene-2,9-dione

4-hydroxy-12,17-dimethyl-13-oxa-16-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(17),3,5,7,10-pentaene-2,9-dione

C17H15NO4 (297.1001)


   

(1s,4s)-4-hydroxy-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7',9',11'-pentaen-13'-one

(1s,4s)-4-hydroxy-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7',9',11'-pentaen-13'-one

C17H15NO4 (297.1001)


   

(3e)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]indol-2-ol

(3e)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]indol-2-ol

C17H15NO4 (297.1001)


   

2-[6-hydroxy-2-(methylimino)-3h-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-hydroxy-2-(methylimino)-3h-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


   

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(1-hydroxyethyl)-4-sulfanyloxolan-3-ol

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(1-hydroxyethyl)-4-sulfanyloxolan-3-ol

C11H15N5O3S (297.0896)


   

(1r,4s)-4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

(1r,4s)-4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

C17H15NO4 (297.1001)


   

(13s)-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaen-20-ol

(13s)-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaen-20-ol

C17H15NO4 (297.1001)


   

4-hydroxy-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7',9',11'-pentaen-13'-one

4-hydroxy-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7',9',11'-pentaen-13'-one

C17H15NO4 (297.1001)


   

5-hydroxy-7-methoxy-4,6-dimethyl-2-phenylisoindole-1,3-dione

5-hydroxy-7-methoxy-4,6-dimethyl-2-phenylisoindole-1,3-dione

C17H15NO4 (297.1001)


   

1-[(s)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

1-[(s)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

C17H15NO4 (297.1001)


   

1-(3-hydroxybenzoyl)-6-methoxy-3,4-dihydroisoquinolin-7-ol

1-(3-hydroxybenzoyl)-6-methoxy-3,4-dihydroisoquinolin-7-ol

C17H15NO4 (297.1001)


   

4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one

C17H15NO4 (297.1001)


   

n-[5-(4-ethenylphenoxycarbonyl)-2-hydroxyphenyl]ethanimidic acid

n-[5-(4-ethenylphenoxycarbonyl)-2-hydroxyphenyl]ethanimidic acid

C17H15NO4 (297.1001)


   

(3ar,7as)-3a-hydroxy-1-(3-phenylprop-2-enoyl)-7,7a-dihydro-3h-indole-2,6-dione

(3ar,7as)-3a-hydroxy-1-(3-phenylprop-2-enoyl)-7,7a-dihydro-3h-indole-2,6-dione

C17H15NO4 (297.1001)